Durham’s Kriya Therapuetics lands $80M to advance gene therapies for diabetes, severe obesity
Series A investors include QVT, Dexcel Pharma, Foresite Capital, Bluebird Ventures (associated with Sutter Hill Ventures), Narya Capital, Amplo, Paul Manning, and Asia Alpha.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
